share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4:持股變動聲明-董事 SACHS BRUCE I
美股sec公告 ·  04/18 04:11
牛牛AI助理已提取核心訊息
In a recent transaction, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a stock transaction on April 15, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.
In a recent transaction, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a stock transaction on April 15, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement. This information is critical for investors to understand the potential impact of the transaction on their investment decisions.
在最近的一筆交易中,與Vertex Pharmicals Inc.(VRTX)關聯的布魯斯·薩克斯於2024年4月15日執行了一項股票交易。公告中沒有披露有關股票性質、交易股票數量、交易價格以及交易後由此產生的所有權的具體細節。這些信息對於投資者了解交易對其投資決策的潛在影響至關重要。
在最近的一筆交易中,與Vertex Pharmicals Inc.(VRTX)關聯的布魯斯·薩克斯於2024年4月15日執行了一項股票交易。公告中沒有披露有關股票性質、交易股票數量、交易價格以及交易後由此產生的所有權的具體細節。這些信息對於投資者了解交易對其投資決策的潛在影響至關重要。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。